In acute myeloid leukemia (AML), BRD4 has been reported to be critical for disease maintenance and suppression of BRD4 led to significant antileukemic effects in vitro and in vivo (Zuber et al., 2011). Here, BRD4 is linked to acute myeloid leukemia.